Aethlon Aims To Lure Drug Makers To Device Biz With Disease-Filtering Technology
This article was originally published in The Pink Sheet Daily
CEO Jim Joyce says firm is in early discussions with several drug companies about prospects to partner on product development with the newly introduced Aethlon ADAPT filtration platform technology.
You may also be interested in...
The realization that combination drug therapy for HIV can lose its clout over time has prompted device makers to focus efforts on projects that may represent new hope to patients otherwise out of options
Industry survey outlines challenges of globalization cited by medtech execs, including potential for insufficient supply chain visibility. Report suggests IT improvements and “on-demand visibility” solutions could help iron out the kinks.
Written comments were due May 7 on the Internal Revenue Service’s proposed regulation to implement a 2.3% excise tax on device sales in the lead-up to a May 16 public hearing.